Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a Bladder

Autor: Barbara B.M. Kortmann, Paul J. Geutjes, Dorien M. Tiemessen, Willeke F. Daamen, Paul K J D de Jonge, Toin H. van Kuppevelt, Elly M. M. Versteeg, Egbert Oosterwijk, L.A.J. Roelofs, Wout F.J. Feitz, Robert P.E. de Gier
Rok vydání: 2018
Předmět:
Scaffold
Swine
Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]
Urinary Bladder
030232 urology & nephrology
Biomedical Engineering
Bioengineering
02 engineering and technology
Fibroblast growth factor
Biochemistry
Biomaterials
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Tissue engineering
Fibrosis
Epidermal growth factor
Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15]
medicine
Animals
Tissue Engineering
Tissue Scaffolds
Chemistry
Heparin
Regeneration (biology)
021001 nanoscience & nanotechnology
medicine.disease
Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]
Vascular endothelial growth factor
Urodynamics
Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10]
Bladder augmentation
Female
Fibroblast Growth Factor 2
Collagen
0210 nano-technology
Biomedical engineering
Heparin-binding EGF-like Growth Factor
Zdroj: Tissue Engineering Part A, 24, 11-20
Tissue Engineering Part A, 24, (1-2), pp. 11-20
ISSN: 1937-3341
Popis: Tissue engineering may become an alternative to current bladder augmentation techniques. Large scaffolds are needed for clinically significant augmentation, but can result in fibrosis and graft shrinkage. The purpose of this study was to investigate the use of multiple scaffolds instead of one large scaffold, to enhance bladder tissue regeneration and bladder capacity. Second, acellular collagen, collagen-heparin, and collagen-heparin scaffolds with growth factors (GFs) were used and the biological activity of the different scaffolds was compared in a large animal model.Scaffolds were made of bovine type I collagen with or without heparin (Ø = 3.2 cm). Collagen-heparin scaffolds were loaded with GFs, vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF2), and heparin-binding epidermal growth factor (HB-EGF). Three identical scaffolds prepared from collagen (COL-group), collagen with heparin (COLHEP-group), or collagen-heparin with growth factors (COLHEPGF-group) were implanted in one porcine bladder. The outcome was compared with sham-operated animals (Sham-group), in which no scaffold was used. Urodynamic evaluation was performed before surgery and 3 months after bladder reconstruction, together with histological evaluation.Survival rate was 92%, 12 animals completed the study, 3 of every group, 1 animal developed peritonitis due to urine leakage and was sacrificed. The regenerated area was largest in the COLHEP-group, and least in the COL-group (p = 0.002). Histological evaluation revealed a normal urothelial layer and good angiogenesis in all groups, and comparable ingrowth of smooth muscle cells. Urodynamics showed no statistically significant differences in bladder capacity and compliance between groups. Bladder capacity and compliance was very high in this animal model, which made it impossible to study the increase due to augmentation.Implantation of multiple collagen-heparin scaffolds in one bladder is feasible in a porcine model, resulting in tissue almost indistinguishable from native tissue involving all cell layers of the bladder. Collagen scaffolds with heparin incorporated resulted in a larger area of regenerated tissue. To reach clinically significant augmentation, multiple larger collagen-heparin scaffolds, with or without GFs, need to be tested to study the largest possible diameter of scaffold and number of used scaffolds still resulting in well-vascularized tissue.
Databáze: OpenAIRE